The round was co-led by new investors Columbus Venture Partners and Mérieux Equity Partners, with participation from additional investors COFIDES and Korys, alongside all existing investors Alta Life...
InceptionBio will focus on identifying, developing, and building new companies based on excellent science, with a special emphasis on Spain. The fund will primarily invest in technology transfer proje...
UCB, a global biopharmaceutical company, has announced that it has entered into a definitive agreement under which UCB would acquire Neurona Therapeutics, an Ysios Capital portfolio company, including...
The financing round was led by Jeito Capital, with participation from additional new investors Vida Ventures, BPI France, and EIFO (Export and Investment Fund of Denmark), as well as all existing inve...
InceptionBio, Ysios’ fourth vehicle, will focus on identifying and building companies based on cutting-edge science, with a special emphasis on Spain. The fund will invest in technology transfer pro...
It has secured €37.5m from the EIB, supported under the European Commission’s Invest EU programme, and €10m from existing investors, including EQT, investing from its LSP Health Economics Fund 2...
Ona Therapeutics is a pioneer in the development of first-in-class antibody-drug conjugates (ADCs) that leverage the molecular basis of advanced cancer. Through collaboration with academic and clinica...
The Series B financing was co-led by new investors EQT Life Sciences and Sanofi Ventures, with participation from Roche Venture Fund, as well as all existing investors: New Enterprise Associates, UCB ...
ReproNovo, a company dedicated to developing innovative treatments for reproductive medicine and women’s health, today announced the successful closing of a $65 million Series A financing round. The...
La inversión del Telescope Biotech Fund sigue una metodología altamente especializada, con una selección cuidada y rigurosa de compañías biotech y farmacéuticas. La firma identifica las tecnolog...
The financing round was led by TCGX, with participation from new investors TPG Life Sciences Innovations, Orbimed Advisors, Venrock Healthcare Capital Partners, Surveyor Capital (a Citadel company), a...
AELIX Therapeutics, a biopharmaceutical company backed by Ysios Capital based in Barcelona, Spain, that focuses on HIV vaccine development, today announced that Gilead Sciences, Inc. (Nasdaq: GILD), b...